April 9, 2025 10:28 AM EDT
News Briefing

Idor­sia’s blood pres­sure pill no longer re­quires a REMS; Solu rais­es $41M

ENDPOINTS

Plus, news about Vin­cerx and Cy­to­ra:

Idor­sia’s Tryvio gets safe­ty re­stric­tion re­moved: Pa­tients tak­ing Idor­sia’s blood pres­sure pill no longer have …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mar­ket tur­moil is tank­ing biotech M&A and IPOs. Here's the play­book star­tups will use to sur­vive

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

Ex­clu­sive: Meri­da Bio­sciences gets $121M to treat au­toim­mune and al­ler­gy dis­eases at their roots

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

A service from the Financial Times